The great fluid debate: When will physiology prevail?

Anesthesiology

Volumn 119, Issue 2, 2013, Pages 248-249

  Ince, Can ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH;

CLINICAL TRIAL (TOPIC); CRYSTALLOID; EDITORIAL; HEART SURGERY; HEMATOCRIT; HEMODILUTION; HUMAN; KIDNEY FUNCTION; MICROCIRCULATION; OXYGENATION; PHYSIOLOGY; PRIORITY JOURNAL; RESUSCITATION; VENOUS PRESSURE;

ANIMALS; EDEMA; FEMALE; HEMODILUTION; KIDNEY; KIDNEY DISEASES; MICROVESSELS; OXYGEN;

EID: 84880883943     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31829bdb4b     Document Type: Editorial

References (9)

1. Konrad FM, Mik EG, Bodmer SIA, Ates NB, Willems HFEM, Klingel K, De Geus HRH, Stolker RJ, Johannes T: Acute nor-movolemic hemodilution in the pig is associated with renal tissue edema, impaired renal microvascular oxygenation and functional loss. ANESTHESIoloGy 2013; 119:256-69
2. Legrand M, Mik EG, Balestra GM, Lutter R, Pirracchio R, Payen D, Ince C: Fluid resuscitation does not improve renal oxy-genation during hemorrhagic shock in rats. ANESTHESIoloGy 2010; 112:119-27
3. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller T P, Winkel P, Wetterslev J; 6S Trial Group; Scandinavian Critical Care Trials Group: Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367:124-34
4. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA; CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group: Hydroxyethyl starch or saline for fuid resuscitation in intensive care. N Engl J Med 2012; 367:1901-11
5. Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J, Forceville X, Feissel M, Hasselmann M, Heininger A, Van Aken H: Assessment of hemodynamic effcacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fuid replacement in patients with severe sepsis: The CRySTMAS study. Crit Care 2012; 16:R94
6. Shafer SL: Shadow of doubt. Anesth Analg 2011; 112:498-500
7. Reinhart K, Perner A, Sprung CL, Jaeschke R, Schortgen F, Johan Groeneveld AB, Beale R, Hartog CS; European Society of Intensive Care Medicine: Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 2012; 38:368-83
8. Dubin A, Pozo MO, Casabella CA, Murias G, Pálizas F JR, Moseinco MC, Kanoore Edul VS, Pálizas F, Estenssoro E, Ince C: Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. J Crit Care 2010; 25:659.e1-8
9. Payen D, De Pont AC, Sakr Y, Spies C, Reinhart K, Vincent Jl; Sepsis occurrence in Acutely Ill Patients (SoAP) Investigators: A positive fuid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008; 12:R74